The WHO has advised against the use of two antibody therapies against COVID – here’s what that means
The WHO has advised against the use of two antibody therapies against COVID – here’s what that means: Sotrovimab and casirivimab-imdevimab are no longer recommended for patients with COVID. ice_blue/Shutterstock New guidance from the World Health Organization (WHO) strongly advises against using the antibody therapies sotrovimab and casirivimab-imdevimab to treat patients with COVID-19. This guidance, …
